Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Barclays PLC
Barclays PLC lifted its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 15.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 266,066 shares of the company’s stock after acquiring an additional 35,889 shares during the period. Barclays PLC’s holdings […]
